These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35257905)

  • 1. Bacterial co-infection at hospital admission in patients with COVID-19.
    Moreno-García E; Puerta-Alcalde P; Letona L; Meira F; Dueñas G; Chumbita M; Garcia-Pouton N; Monzó P; Lopera C; Serra L; Cardozo C; Hernandez-Meneses M; Rico V; Bodro M; Morata L; Fernandez-Pittol M; Grafia I; Castro P; Mensa J; Martínez JA; Sanjuan G; Marcos MA; Soriano A; Garcia-Vidal C;
    Int J Infect Dis; 2022 May; 118():197-202. PubMed ID: 35257905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study.
    Garcia-Vidal C; Sanjuan G; Moreno-García E; Puerta-Alcalde P; Garcia-Pouton N; Chumbita M; Fernandez-Pittol M; Pitart C; Inciarte A; Bodro M; Morata L; Ambrosioni J; Grafia I; Meira F; Macaya I; Cardozo C; Casals C; Tellez A; Castro P; Marco F; García F; Mensa J; Martínez JA; Soriano A;
    Clin Microbiol Infect; 2021 Jan; 27(1):83-88. PubMed ID: 32745596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.
    Hughes S; Troise O; Donaldson H; Mughal N; Moore LSP
    Clin Microbiol Infect; 2020 Oct; 26(10):1395-1399. PubMed ID: 32603803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands.
    Karami Z; Knoop BT; Dofferhoff ASM; Blaauw MJT; Janssen NA; van Apeldoorn M; Kerckhoffs APM; van de Maat JS; Hoogerwerf JJ; Ten Oever J
    Infect Dis (Lond); 2021 Feb; 53(2):102-110. PubMed ID: 33103530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Searching for a role of procalcitonin determination in COVID-19: a study on a selected cohort of hospitalized patients.
    Dolci A; Robbiano C; Aloisio E; Chibireva M; Serafini L; Falvella FS; Pasqualetti S; Panteghini M
    Clin Chem Lab Med; 2020 Nov; 59(2):433-440. PubMed ID: 33554505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary bacterial infections in adult patients hospitalized for COVID-19 in standard wards.
    Husain M; Valayer S; Poey N; Rondinaud E; d'Humières C; Visseaux B; Lariven S; Lescure FX; Deconinck L
    Infect Dis Now; 2022 Jun; 52(4):208-213. PubMed ID: 34896662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic yield of bacteriological tests and predictors of severe outcome in adult patients with COVID-19 presenting to the emergency department.
    Kaal A; Snel L; Dane M; van Burgel N; Ottens T; Broekman W; El Bouazzaoui L; Kolfschoten N; Schippers E; Steyerberg E; Meziyerh S; van Nieuwkoop C
    Emerg Med J; 2021 Sep; 38(9):685-691. PubMed ID: 34289966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial and Fungal Coinfection in Critically Ill COVID-19 Cases and Predictive Role of Procalcitonin During the First Wave at an Academic Health Center.
    Alnimr AM; Alshahrani MS; Alwarthan S; AlQahtani SY; Hassan AA; BuMurah NN; Alhajiri S; Bukharie H
    J Epidemiol Glob Health; 2022 Jun; 12(2):188-195. PubMed ID: 35397070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High procalcitonin levels associated with increased intensive care unit admission and mortality in patients with a COVID-19 infection in the emergency department.
    Tong-Minh K; van der Does Y; Engelen S; de Jong E; Ramakers C; Gommers D; van Gorp E; Endeman H
    BMC Infect Dis; 2022 Feb; 22(1):165. PubMed ID: 35189826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and etiological analysis of co-infections and secondary infections in COVID-19 patients: An observational study.
    Chen S; Zhu Q; Xiao Y; Wu C; Jiang Z; Liu L; Qu J
    Clin Respir J; 2021 Jul; 15(7):815-825. PubMed ID: 33818909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial co-infections in community-acquired pneumonia caused by SARS-CoV-2, influenza virus and respiratory syncytial virus.
    Hedberg P; Johansson N; Ternhag A; Abdel-Halim L; Hedlund J; Nauclér P
    BMC Infect Dis; 2022 Jan; 22(1):108. PubMed ID: 35100984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive model for bacterial co-infection in patients hospitalized for COVID-19: a multicenter observational cohort study.
    Giannella M; Rinaldi M; Tesini G; Gallo M; Cipriani V; Vatamanu O; Campoli C; Toschi A; Ferraro G; Horna CS; Bartoletti M; Ambretti S; Violante F; Viale P; Curti S
    Infection; 2022 Oct; 50(5):1243-1253. PubMed ID: 35488112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low frequency of community-acquired bacterial co-infection in patients hospitalized for COVID-19 based on clinical, radiological and microbiological criteria: a retrospective cohort study.
    Coenen S; de la Court JR; Buis DTP; Meijboom LJ; Schade RP; Visser CE; van Hest R; Kuijvenhoven M; Prins JM; Nijman SFM; Sieswerda E; Sigaloff KCE
    Antimicrob Resist Infect Control; 2021 Oct; 10(1):155. PubMed ID: 34717761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein and procalcitonin for antimicrobial stewardship in COVID-19.
    Pink I; Raupach D; Fuge J; Vonberg RP; Hoeper MM; Welte T; Rademacher J
    Infection; 2021 Oct; 49(5):935-943. PubMed ID: 34021897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial and fungal co-infections among ICU COVID-19 hospitalized patients in a Palestinian hospital: a retrospective cross-sectional study.
    Naseef HA; Mohammad U; Al-Shami N; Sahoury Y; Abukhalil AD; Dreidi M; Alsahouri I; Farraj M
    F1000Res; 2022; 11():30. PubMed ID: 35811795
    [No Abstract]   [Full Text] [Related]  

  • 16. Elevated procalcitonin concentrations in severe Covid-19 may not reflect bacterial co-infection.
    Heer RS; Mandal AK; Kho J; Szawarski P; Csabi P; Grenshaw D; Walker IA; Missouris CG
    Ann Clin Biochem; 2021 Sep; 58(5):520-527. PubMed ID: 34018843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High rate of bacterial respiratory tract co-infections upon admission amongst moderate to severe COVID-19 patients.
    Cohen R; Finn T; Babushkin F; Geller K; Alexander H; Shapiro M; Uda M; Mostrchy AR; Amash R; Shimoni Z; Paikin S; Ilani A; Lellouche J
    Infect Dis (Lond); 2022 Feb; 54(2):134-144. PubMed ID: 34606393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia.
    Chong WH; Saha BK; Ananthakrishnan Ramani ; Chopra A
    Infection; 2021 Aug; 49(4):591-605. PubMed ID: 33709380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of antibiotics with the outcomes in COVID-19 pneumonia patients with elevated PCT levels.
    Raavi L; Isha S; Jonna S; Craver EC; Nataraja H; Jenkins A; Hanson AJ; Venkataraman AB; Balasubramanian P; Tekin A; Bansal V; Caples SM; Khan SA; Jain NK; LaNou AT; Kashyap R; Cartin-Ceba R; Patel BM; Milian RD; Venegas CP; Shapiro AB; Bhattacharyya A; Chaudhary S; Kiley SP; Erben YM; Quinones QJ; Patel NM; Guru PK; Franco PM; Roy A; Sanghavi DK
    Respir Med; 2024 Sep; 231():107697. PubMed ID: 38857810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-infection in patients with hypoxemic pneumonia due to COVID-19 in Reunion Island.
    Allou N; Larsen K; Dubernet A; Traversier N; Masse L; Foch E; Bruneau L; Maillot A; André M; Lagrange-Xelot M; Allyn J; Thomas V; Coolen-Allou N
    Medicine (Baltimore); 2021 Jan; 100(4):e24524. PubMed ID: 33530280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.